Reply to: Radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor > 4 cm?

被引:0
|
作者
Marti, J. L. [1 ]
Morris, L. G. T. [2 ]
Ho, A. S. [3 ]
机构
[1] New York Presbyterian Lower Manhattan Hosp, Weill Cornell Med, Dept Surg, 156 William St,12th Floor, New York, NY 10038 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, 1275 York Ave, New York, NY 10065 USA
[3] Cedars Sinai Med Ctr, Dept Surg, 8635 West 3rd St,Suite 590W, Los Angeles, CA 90048 USA
来源
EJSO | 2017年 / 43卷 / 09期
关键词
D O I
10.1016/j.ejso.2017.06.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1804 / 1804
页数:1
相关论文
共 50 条
  • [1] Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor > 4 cm?
    Rosario, P. W.
    [J]. EJSO, 2017, 43 (09): : 1802 - 1803
  • [2] Radioiodine Ablation in Low-Risk Thyroid Cancer REPLY
    Alexander, Erik K.
    Larsen, P. Reed
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07): : 674 - 675
  • [3] Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid Carcinoma
    Hay, Ian D.
    Kaggal, Suneetha
    Iniguez-Ariza, Nicole M.
    Reinalda, Megan S.
    Wiseman, Gregory A.
    Thompson, Geoffrey B.
    [J]. MAYO CLINIC PROCEEDINGS, 2021, 96 (07) : 1727 - 1745
  • [4] Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
    Schlumberger, Martin
    Catargi, Bogdan
    Borget, Isabelle
    Deandreis, Desiree
    Zerdoud, Slimane
    Bridji, Boumediene
    Bardet, Stephane
    Leenhardt, Laurence
    Bastie, Delphine
    Schvartz, Claire
    Vera, Pierre
    Morel, Olivier
    Benisvy, Danielle
    Bournaud, Claire
    Bonichon, Francoise
    Dejax, Catherine
    Toubert, Marie-Elisabeth
    Leboulleux, Sophie
    Ricard, Marcel
    Benhamou, Ellen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (18): : 1663 - 1673
  • [5] Is radioiodine ablation necessary in small (≤1 cm) papillary and follicular thyroid carcinomas?
    Riemann, B.
    Hutzenlaub, V.
    Schober, O.
    [J]. HORMONE RESEARCH, 2007, 68 : 21 - 21
  • [6] Monitoring of low-risk patients with papillary thyroid carcinoma
    Menzel, C
    Grünwald, F
    Biersack, HJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09): : 4507 - 4507
  • [7] Is radioiodine therapy necessary in small (≤ 1 cm) papillary and follicular thyroid carcinoma?
    Riemann, B.
    Hutzenlaub, V.
    Schober, O.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S229 - S230
  • [8] APPLICATION OF POST-SURGICAL STIMULATED THYROGLOBULIN FOR RADIOIODINE REMNANT ABLATION SELECTION IN LOW-RISK PAPILLARY THYROID CARCINOMA
    Vaisman, Alon
    Orlov, Steven
    Yip, Jonathan
    Hu, Cindy
    Lim, Terence
    Dowar, Mark
    Freeman, Jeremy L.
    Walfish, Paul G.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (06): : 689 - 698
  • [9] Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer
    Pacini, Furio
    [J]. EUROPEAN THYROID JOURNAL, 2016, 5 (01) : 7 - +
  • [10] Radioiodine ablation of contralateral normal lobe in low-risk carcinoma thyroid patients following hemithyroidectomy.
    Bal, CS
    Kumar, A
    Dwivedi, SN
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 207P - 207P